- Home
- CVS
CVS
CVS Health Corporation
as 02-21-2025 4:00pm EST
| Founded: | 1963 | Country: | United States |
| Employees: | N/A | City: | WOONSOCKET |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $69.75 | AVG Volume (30 days): | 12.5M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.66 | EPS Growth: | -43.43 |
| 52 Week Low/High: | $43.56 - $80.75 | Next Earning Date: | 02-12-2025 |
| Revenue: | $370,656,000,000 | Revenue Growth: | 3.93% |
| Revenue Growth (this year): | 5.82% | Revenue Growth (next year): | 5.15% |
Stock Insider Trading Activity of CVS Health Corporation (CVS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mahoney Michael F | CVS | Director | Feb 18 '25 | Buy | $66.70 | 30,000 | $2,001,000.00 | 39,356 |
Latest CVS Health Corporation News
CVS Breaking Stock News: Dive into CVS Ticker-Specific Updates for Smart Investing
Reuters
a day ago
CVS cuts bonuses after low profit levels in 2024
The Wall Street Journal
a day ago
Why Is Warren Buffett Hoarding So Much Cash?
Barrons.com
a day ago
CVS Stock Is Soaring. A Director Bets $2 Million on the Rally.
The Wall Street Journal
2 days ago
It’s No Longer Business as Usual for UnitedHealth, or the Entire Healthcare Industry
Investor's Business Daily
2 days ago
CVS Health Stock Gets RS Rating Upgrade
Argus Research
3 days ago
Daily – Vickers Top Buyers & Sellers for 02/20/2025
Yahoo Finance
3 days ago
'Health insurance companies are always going to need a PBM': CVS president Prem Shah
The Wall Street Journal
3 days ago
X Hinted at Possible Deal Trouble in Talks With Ad Giant to Increase Spending
Compare CVS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CVS CVS Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.